SC 13G: CASTLE BIOSCIENCES INC
Ticker: CSTL · Form: SC 13G · Filed: 2024-02-13T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by CASTLE BIOSCIENCES INC.
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0001126328-24-000069 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G - Statement of Beneficial Ownership by Certain Investors: SEC Accession No. 0001126328-24-000069 Filing Date 2024-02-13 Accepted 2024-02-13 14:07:38 Documents 1 Document Format Files Seq Description Document Type Size 1 PGI_13G_14843C105_202312.txt SC 13G 4775 Complete submission text file 0001126328-24-000069.txt 6632 Mailing Address 711 HIGH STREET DES MOINES IA 50392-0300 Business Address 711 HIGH STREET DES MOINES IA 50392-0300 515-247-5111 PRINCIPAL GLOBAL INVESTORS (Filed by) CIK : 0000769734 (see all company filings) EIN. : 421479618 Type: SC 13G Mailing Address 505 S FRIENDSWOOD DRIVE SUITE 401 FRIENDSWOOD TX 77546 Business Address 505 S FRIENDSWOOD DRIVE SUITE 401 FRIENDSWOOD TX 77546 866-788-9007 CASTLE BIOSCIENCES INC (Subject) CIK : 0001447362 (see all company filings) EIN. : 770701774 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G | Act: 34 | File No.: 005-91094 | Film No.: 24624615 SIC : 8071 Services-Medical Laboratories (CF Office: 08 Industrial Applications and Services)